MAPT and Cognitive impairment: This study found that ASS could improve STZ-induced cognitive deficits in rats by regulating DAPK1 expression in hippocampal tissues and inhibiting the over-phosphorylation of the Tau protein while simultaneously reducing the expression of neuroinflammatory factors in hippocampal tissues.